Pediatric Vaccines Market Size Trends, Analysis, and Forecast till 2035
Description
The Pediatric Vaccines Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Pediatric vaccines market are specifically designed to protect children from various types of infectious diseases. These Vaccines help to build immunity and prevent from serious illness that can be harmful for children. Pediatric Vaccines contains, Hepatitis B, rotavirus Vaccines polio, and others, this Vaccines help to prevent spread of infectious diseases. The increasing number of births in developing regions drives the demand for pediatric Vaccines, as more children need immunization to protect against a variety of diseases, contributing to drive pediatric Vaccines market size.
Report Highlights:
Pediatric vaccines market size is accounted for USD 50.6 Billion in 2025.
Pediatric vaccines market size is anticipated to expand at a rate of USD 121.3 Billion by 2035, and increasing at a CAGR of 10.1%.
Based on Vaccines type, multivalent vaccines segment dominates in pediatric Vaccines market share.
On the basis of technology, live attenuated vaccines segment holds the major pediatric Vaccines market share.
By route of administration, the pediatric Vaccines market is dominated by intramuscular injection segment.
Based on indication MMR segment has highest pediatric vaccines market share over forecast period.
By distribution channel, hospital is the leading segment pediatric vaccines market size.
North America is the dominating region in pediatric vaccines market growth.
The Asia Pacific is expected as fastest growing segment in target market.
Key Highlights
In October 2024, The World Health Organization (WHO) recommended a new Vaccines, R21/Matrix-M, for the prevention of malaria in children. WHO also issued recommendations on the advice of SAGE for new Vaccines for dengue and meningitis, and IA2030 for polio. R21 is high efficient Vaccines by reduces the symptomatic cases of malaria by 75% during 12 months following a 3-dose series.
Report Analysis:
Antimicrobial Therapy in Pediatric Vaccines:
Antimicrobial therapy refers to the use of medications, such as antibiotics, antifungals, antivirals, or antiparasitics to treat infections caused by microorganisms. In the pediatric Vaccines, antimicrobial therapy plays an indirect but essential role in the prevention of infections. Vaccines are designed to prevent diseases by stimulating the child’s immune system to recognize and fight specific pathogens, such as bacteria, viruses before it can cause illness. When children receive Vaccines, this are not directly treated with antimicrobial drugs, instead, given immunity against infections, which reduces the probability of needing antimicrobial therapy in the future.
Segmentation:
By Vaccine Type:
Pfizer Inc.
BioNTech SE
SINOVAC
Moderna, Inc.
Merck & Co., Inc.
GSK plc.
AstraZeneca
Johnson & Johnson Services, Inc.
Indian Immunologicals Ltd.
Zydus Group.
Serum Institute of India Pvt. Ltd.
Sanofi
Zhi Fei Biological
Dynavax Technologies
Panacea Biotec
FFF Enterprises, Inc.
What You’ll Gain from This Report:
FAQs:
Key Questions Answered in the Report.
1. What was the Pediatric Vaccines Market size in 2025?
2. What is projected growth rate of the Pediatric Vaccines Market during 2025-2035?
3. What are the key factors driving the Pediatric Vaccines Market growth?
4. What are leading players in the Pediatric Vaccines Market?
5. What are the key regions analyzed in the Pediatric Vaccines Market?
6. Which region is dominating in the Pediatric Vaccines Market?
Pediatric vaccines market are specifically designed to protect children from various types of infectious diseases. These Vaccines help to build immunity and prevent from serious illness that can be harmful for children. Pediatric Vaccines contains, Hepatitis B, rotavirus Vaccines polio, and others, this Vaccines help to prevent spread of infectious diseases. The increasing number of births in developing regions drives the demand for pediatric Vaccines, as more children need immunization to protect against a variety of diseases, contributing to drive pediatric Vaccines market size.
Report Highlights:
Pediatric vaccines market size is accounted for USD 50.6 Billion in 2025.
Pediatric vaccines market size is anticipated to expand at a rate of USD 121.3 Billion by 2035, and increasing at a CAGR of 10.1%.
Based on Vaccines type, multivalent vaccines segment dominates in pediatric Vaccines market share.
On the basis of technology, live attenuated vaccines segment holds the major pediatric Vaccines market share.
By route of administration, the pediatric Vaccines market is dominated by intramuscular injection segment.
Based on indication MMR segment has highest pediatric vaccines market share over forecast period.
By distribution channel, hospital is the leading segment pediatric vaccines market size.
North America is the dominating region in pediatric vaccines market growth.
The Asia Pacific is expected as fastest growing segment in target market.
Key Highlights
In October 2024, The World Health Organization (WHO) recommended a new Vaccines, R21/Matrix-M, for the prevention of malaria in children. WHO also issued recommendations on the advice of SAGE for new Vaccines for dengue and meningitis, and IA2030 for polio. R21 is high efficient Vaccines by reduces the symptomatic cases of malaria by 75% during 12 months following a 3-dose series.
Report Analysis:
Antimicrobial Therapy in Pediatric Vaccines:
Antimicrobial therapy refers to the use of medications, such as antibiotics, antifungals, antivirals, or antiparasitics to treat infections caused by microorganisms. In the pediatric Vaccines, antimicrobial therapy plays an indirect but essential role in the prevention of infections. Vaccines are designed to prevent diseases by stimulating the child’s immune system to recognize and fight specific pathogens, such as bacteria, viruses before it can cause illness. When children receive Vaccines, this are not directly treated with antimicrobial drugs, instead, given immunity against infections, which reduces the probability of needing antimicrobial therapy in the future.
Segmentation:
By Vaccine Type:
- Monovalent
- Multivalent
- Live Attenuated Vaccines
- Subunit Vaccines
- Viral Vector Vaccines
- Toxoid Vaccines
- mRNA Vaccines
- Inactivated Vaccines
- Nasal
- Subcutaneous Injection
- Intramuscular Injection
- Oral Delivery System
- Polio
- Measles, Mumps, & Rubella
- Influenza
- Hepatitis A&B
- Rotavirus
- Others
- Hospitals
- Government Organization
- Healthcare Institutions
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Pfizer Inc.
BioNTech SE
SINOVAC
Moderna, Inc.
Merck & Co., Inc.
GSK plc.
AstraZeneca
Johnson & Johnson Services, Inc.
Indian Immunologicals Ltd.
Zydus Group.
Serum Institute of India Pvt. Ltd.
Sanofi
Zhi Fei Biological
Dynavax Technologies
Panacea Biotec
FFF Enterprises, Inc.
What You’ll Gain from This Report:
- Regional & Country-Specific Insights: Unlock detailed market share analysis across key regions and countries, empowering you to pinpoint growth opportunities and optimize your strategic positioning.
- Guidance for Market Entry: Expert-backed strategies to overcome entry barriers, establish a foothold, and accelerate expansion in new or competitive markets.
- Reliable Long-Term Forecasts: Data-driven projections from 2025 to 2035, including pivotal milestones for 2025, 2026, and 2030, ensuring confident, future-proof investments.
- In-Depth Market Trend Analysis: Explore the forces shaping the industry—drivers, challenges, emerging opportunities, and risks—along with insights into high-growth sectors and potential obstacles.
- Proven Business Strategies: Actionable, data-backed recommendations tailored to key market segments, helping you maximize profitability and outperform competitors.
- Competitive Intelligence: Stay ahead with a clear view of industry trends, competitor strategies, and untapped market potential to refine your approach.
- Exclusive Company Profiles: In-depth analysis of top market players, including business models, financial performance, strategic initiatives, and recent developments.
- Innovative Supply Chain Trends: Discover the latest technological advancements transforming supply chains—boosting efficiency, cutting costs, and driving innovation.
FAQs:
Key Questions Answered in the Report.
1. What was the Pediatric Vaccines Market size in 2025?
2. What is projected growth rate of the Pediatric Vaccines Market during 2025-2035?
3. What are the key factors driving the Pediatric Vaccines Market growth?
4. What are leading players in the Pediatric Vaccines Market?
5. What are the key regions analyzed in the Pediatric Vaccines Market?
6. Which region is dominating in the Pediatric Vaccines Market?
Table of Contents
178 Pages
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccines Type
- Market Snippet, By Technology
- Market Snippet, By Route of Administration
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Recent Product Approval
- Pipeline Analysis
- Import/Export Data
- Market Segmentation, By Vaccines Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Monovalent
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Multivalent
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Technology, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Live Attenuated Vaccines
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Subunit Vaccines
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Viral Vector Vaccines
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Toxoid Vaccines
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- mRNA Vaccines
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Inactivated Vaccines
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Route of Administration, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Nasal
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Subcutaneous Injection
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Intramuscular Injection
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Oral Delivery System
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Indication, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Polio
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Measles, Mumps, & Rubella
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Influenza
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Hepatitis A&B
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Rotavirus
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Distribution Channel, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Government Organizations
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnostics Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Vaccines Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Vaccines Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Vaccines Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Vaccines Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Bn), By Vaccines Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Indication, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East and Africa
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
